Fulgent Genetics, Inc. (FLGT) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
FLGT currently has 30.7M outstanding shares. with limited dilution risk as only 1.37M additional shares (4.5%) are authorized for issuance. The company has minimally diluted shareholders by 3.7% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Nov 07, 2025 |
10-Q filing | 30.7M shares outstanding |
31M | 1.4M |
| Aug 01, 2025 |
10-Q filing | 30.5M shares outstanding |
31M | 1.6M |
| May 02, 2025 |
10-Q filing | 30.8M shares outstanding |
31M | 1.3M |
| Feb 28, 2025 |
10-K filing | 30.2M shares outstanding |
30M | 1.9M |
| Nov 08, 2024 |
10-Q filing | 30.4M shares outstanding |
30M | 1.7M |
| Aug 02, 2024 |
10-Q filing | 30.1M shares outstanding |
30M | 2M |
| May 03, 2024 |
10-Q filing | 29.8M shares outstanding |
30M | 2.4M |
| Feb 28, 2024 |
10-K filing | 29.8M shares outstanding |
30M | 2.3M |
| Nov 03, 2023 |
10-Q filing | 30.0M shares outstanding |
30M | 2.1M |
| Aug 04, 2023 |
10-Q filing | 29.8M shares outstanding |
30M | 2.3M |
| May 05, 2023 |
10-Q filing | 29.5M shares outstanding |
30M | 2.6M |
| Feb 28, 2023 |
10-K filing | 30.1M shares outstanding |
30M | 2M |
| Nov 07, 2022 |
10-Q filing | 30.2M shares outstanding |
30M | 1.9M |
| Aug 04, 2022 |
10-Q filing | 30.4M shares outstanding |
30M | 1.8M |
| May 05, 2022 |
10-Q filing | 30.2M shares outstanding |
30M | 1.9M |
| Feb 28, 2022 |
10-K filing | 31.0M shares outstanding |
31M | 1.1M |
| Nov 09, 2021 |
10-Q filing | 29.7M shares outstanding |
30M | 2.4M |
| Aug 10, 2021 |
10-Q filing | 29.2M shares outstanding |
29M | 3M |
| May 07, 2021 |
10-Q filing | 28.8M shares outstanding |
29M | 3.3M |
| Mar 08, 2021 |
10-K filing | 28.9M shares outstanding |
29M | 3.2M |
| Nov 09, 2020 |
10-Q filing | 23.5M shares outstanding |
24M | 8.6M |
| Aug 05, 2020 |
10-Q filing | 21.7M shares outstanding |
22M | 10M |
| Aug 05, 2020 |
8-K filing: Fulgent Genetics, Inc. amended its Equity Distribution Agreement with Piper Sandler & Co. to increase the offering amount of common stock from $30 million to $44.92 million, and as of August 4, 2020, has sold 104,390 shares for gross proceeds of $1,266,878.82. ($1.27M proceeds) |
22M | 11M |
| Aug 05, 2020 |
S-3/A filing: The filing is an S-3/A form indicating the company may offer up to $300 million of any combination of common stock, preferred stock, and debt securities from time to time. |
22M | 11M |
| Jul 21, 2020 |
S-3 filing: Filgent is offering from time to time, we may offer up to $300 million of any combination of common stock, preferred stock, and debt securities. |
22M | 16M |
| May 06, 2020 |
10-Q filing | 21.6M shares outstanding |
22M | 0 |
| Mar 13, 2020 |
10-K filing | 21.6M shares outstanding |
22M | 0 |